Match!
Ibraheim Hajir
King's College London
2Publications
Publications 2
Newest
PURPOSEThe risk of immune checkpoint inhibitor therapy–related GI adverse events in patients with cancer and inflammatory bowel disease (IBD) has not been well described. We characterized GI advers...
Source
Source
1